When clinical trials are suddenly halted by US funding cuts, there are repercussions for investigators and patients, and they do not stop at borders.
Change history
06 October 2025
In the version of the article initially published, the Fig. 2 caption read “Researchers who have had NIH grants cancelled or frozen include...” and has now been corrected to “Researchers whose work has been affected by NIH grant cancellations or freezes to NIH administration include...”. Additionally Ophira Ginsburg’s title has been amended to “Senior Advisor for clinical research”. These corrections have been made to the HTML and PDF versions of the article.
References
Powell, A. Harvard T.H. Chan School of Public Health https://go.nature.com/4mN2i3A (April 15, 2025).
Yourish, K., Daniel, A., Datar, S. White, I. & Gamio, L. The New York Times https://go.nature.com/4ngoVxm (7 March 2025).
Ginsburg, O. et al. Lancet 402, 2113–2166 (2023).
Emanuel, G., Simmons-Duffin, S. & Stein, R. NPR https://go.nature.com/3JMmF2u (22 January 2025).
Faguy, A. BBC https://go.nature.com/4preA3J (2 July 2025).
Nolen, S. The New York Times https://go.nature.com/3HWWqG2 (21 August 2025).
Chen, A., Molteni, M. & Oza, A. STAT https://go.nature.com/3JRxn7I (29 July 2025).
Garisto, D. & Kozlov, M. Nature https://www.nature.com/articles/d41586-025-02721-5 (22 August 2025).
Kaiser, J. Science https://go.nature.com/4622Qvn (15 Aug 2025).
About this article
Cite this article
Guenot, M. The damage done. Nat Med (2025). https://doi.org/10.1038/s41591-025-03994-z
Published: 30 September 2025
DOI: https://doi.org/10.1038/s41591-025-03994-z
.png)


